Evidence map›Paper›PMID 31648381›Full record

ArticleBritish journal of pharmacology2020

Isoprenaline protects intestinal stem cells from chemotherapy-induced damage.

Huihong Zeng, Huan Li, Mengzhen Yue, Ying Fan, Jiaoqi Cheng, Xincheng Wu, Rui Xu, Wuping Yang, Manjun Li, Jiahui Tang and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Huihong ZengDepartment of Occupational Health and Toxicology, Medical College of Nanchang University, Nanchang, China.
Huan LiDepartment of Occupational Health and Toxicology, Medical College of Nanchang University, Nanchang, China.
Mengzhen YueDepartment of Occupational Health and Toxicology, Medical College of Nanchang University, Nanchang, China.
Ying FanDepartment of Occupational Health and Toxicology, Medical College of Nanchang University, Nanchang, China.
Jiaoqi ChengDepartment of Occupational Health and Toxicology, Medical College of Nanchang University, Nanchang, China.
Xincheng WuDepartment of Occupational Health and Toxicology, Medical College of Nanchang University, Nanchang, China.
Rui XuDepartment of Occupational Health and Toxicology, Medical College of Nanchang University, Nanchang, China.
Wuping YangDepartment of Occupational Health and Toxicology, Medical College of Nanchang University, Nanchang, China.
Manjun LiDepartment of Pathology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Jiahui TangDepartment of Occupational Health and Toxicology, Medical College of Nanchang University, Nanchang, China.
Hongping ChenDepartment of Occupational Health and Toxicology, Medical College of Nanchang University, Nanchang, China.
Bohai KuangDepartment of Occupational Health and Toxicology, Medical College of Nanchang University, Nanchang, China.
Guangqin FanDepartment of Occupational Health and Toxicology, Medical College of Nanchang University, Nanchang, China.
Qingxian ZhuDepartment of Occupational Health and Toxicology, Medical College of Nanchang University, Nanchang, China.
Lijian ShaoDepartment of Occupational Health and Toxicology, Medical College of Nanchang University, Nanchang, China.ORCID 0000-0002-7000-7094
Nanchang University · CN

Funding

Graduate Innovation Special Fund of Jiangxi Province YC2016-B028Graduate Innovation Special Fund of Jiangxi Province YC2018-S086National Natural Science Foundation of China 30900574National Natural Science Foundation of China 81160050National Natural Science Foundation of China 81460110,
6 · The paper itself

Abstract

background and purposeDamage to intestinal epithelial cells and mucosa limits the effectiveness of several anti-cancer chemotherapeutic agents but the underlying mechanism (s) remain unknown. Little is known of how enteric nervous system regulates proliferation, differentiation, impairment, and regeneration of intestinal stem cells. Here we have investigated the effects of isoprenaline on the damaged intestinal stem cells induced by chemotherapeutic treatments in mice. EXPERIMENTAL APPROACH: The effects of inhibiting sympathetic and parasympathetic nerves on intestinal stem cells were examined in male C57BL/6J mice. Protection by isoprenaline of intestinal stem cells was assessed in the presence or absence of 5-fluorouracil (5FU) or cisplatin. Cellular apoptosis, cell cycle, PI3K/Akt signalling, and NF-κB signalling in intestinal stem cells were mechanistically evaluated. KEY

resultsThe sympathetic nerve inhibitor 6-OHDA decreased the number and function of intestinal stem cells. 5FU or cisplatin treatment damaged both intestinal stem cells and sympathetic nerves. Notably, isoprenaline accelerated the recovery of intestinal stem cells after 5FU or cisplatin treatment. This protective effect of isoprenaline on damaged intestinal stem cells was mediated by β CONCLUSIONS AND IMPLICATIONS: Treatment with isoprenaline is a new approach to ameliorate the damage to intestinal stem cells following exposure to cancer chemotherapeutic agents.

Indexed as

Antineoplastic AgentsPhosphatidylinositol 3-KinasesAnimalsApoptosisIntestinal MucosaIsoproterenolMaleMiceMice, Inbred C57BLStem CellsAntineoplastic AgentsIsoproterenolPhosphatidylinositol 3-Kinases

Identifiers

PMID31648381
PMCPMC7012967
OpenAlexW2982222598

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.